EUVIMEDSkopri EUVIMED
Crossref

Myelofibrosis With Myeloid Metaplasia And Antiphospholipid Syndrome: Coexistent Etiologies Of Pulmonary Hypertension And Coagulation Factor Ii And V Deficiencies

The Internet Journal of Pulmonary Medicine · 2003

DOI: 10.5580/1131 ↗

At a glance

Journal article in The Internet Journal of Pulmonary Medicine, 2003.

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

We report the first case of myeloid metaplasia with myelofibrosis (MMM) associated with antiphospholipid syndrome (APS) causing pulmonary arterial hypertension (PAH) and coagulation factor V deficiency. Chronic thromboembolic distal PAH occurs in the context of MMM and APS. These procoagulant states may independently involve the arterial and venous system. Therefore, recurrent thromboembolism in thrombophilia associated with MMM and APS may coexist in the development of PH and coagulation factor deficiencies. Abbreviations: MMM: Myeloid Metaplasia with Myelofibrosis; Antiphospholipid Syndrome: APS; Pulmonary Arterial Hypertension: PAH; Myeloproliferative Disorders: MPD.

Cite

APA

(2003). Myelofibrosis With Myeloid Metaplasia And Antiphospholipid Syndrome: Coexistent Etiologies Of Pulmonary Hypertension And Coagulation Factor Ii And V Deficiencies. The Internet Journal of Pulmonary Medicine. https://doi.org/10.5580/1131

Vancouver

Myelofibrosis With Myeloid Metaplasia And Antiphospholipid Syndrome: Coexistent Etiologies Of Pulmonary Hypertension And Coagulation Factor Ii And V Deficiencies. The Internet Journal of Pulmonary Medicine. 2003. doi:10.5580/1131

BibTeX
@article{euvimed2003,
  title = {Myelofibrosis With Myeloid Metaplasia And Antiphospholipid Syndrome: Coexistent Etiologies Of Pulmonary Hypertension And Coagulation Factor Ii And V Deficiencies},
  journal = {The Internet Journal of Pulmonary Medicine},
  year = {2003},
  doi = {10.5580/1131}
}
Start for free →